Sensorimotor dysfunction in HIV/AIDS: Effects of antiretroviral treatment and comorbid psychiatric disorders

AIDS

Volumn 19, Issue 5, 2005, Pages 495-502

  Bauer, Lance O ^a   Ceballos, Natalie A ^a   Shanley, John D ^a   Wolfson, Leslie I ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Gait; Musculoskeletal equilibrium; Sensory neuropathy; Sensory thresholds; Substance related disorders

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOLISM; ARTICLE; BALANCE DISORDER; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG ABUSE; FALLING; FEMALE; FOOT; GAIT DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOBILIZATION; MOTOR DYSFUNCTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RELIABILITY; SAFETY; SENSORY DYSFUNCTION; STRENGTH; TOUCH; WORKPLACE;

EID: 17144365826     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000162338.66180.0b     Document Type: Article

References (43)

1. Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs 2002; 16:663-668.
2. Dal Pan GL, McArthur JC, Harrison MJG. Neurological symptoms in Human Immunodeficiency Virus Infection. In: AIDS & The Nervous System. Berger JR, Levy RM (editors). New York: Lippincott - Raven Publishers. 1997. pp. 141-172.
3. Brew BJ. The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve 2003; 28:542-552.
4. Gilmer WS. Neurologic problems of the lower extremity associated with HIV and AIDS. Clin Podiatr Med Surg 1998; 15:281-303.
5. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 2001; 6:21-27.
6. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000; 59:1251-1260.
7. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multi-focal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4:59-68.
8. Walsh K, Kaye K, Demaerschalk B, Stewart S, Crukley J, Hammond R. AZT myopathy and HIV-1 polymyositis: one disease or two? Can J Neurol Sci 2002; 29:390-393.
9. Masanes F, Pedrol E, Grau JM, Coll-Vincent B, Casademont J, Miro O, Mallolas J, Urbano-Marques A. Symptomatic myopathies in HIV-1 infected patients untreated with antiretroviral agents - a clinico-pathological study of 30 consecutive patients. Clin Neuropathol 1996; 15:221-225.
10. Sclar G, Kennedy CA, Hill JM, McCormack MK. Cerebellar degeneration associated with HIV infection. Neurology 2000; 54:1-12.
11. Tagliati M, Simpson D, Morgello S, Clifford D, Schwartz RL, Berger JR. Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology 1998; 50:244-251.
12. Von Giesen H-J, Wittsack H-J, Wenserki F, Koller H, Hefter H, Arendt G. Basal ganglia abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol 2001; 58:1281-1286.
13. Arendt G, Maecker H, Purrmann J, Homberg V. Control of posture in patients with neurologically asymptomatic HIV infection and patients with beginning HIV-1 related encephalopathy. Arch Neurol 1994; 51:1232-1235.
14. Trenkwalder C, Straube A, Paulus W, Krafcyk S, Scheike E, Einhaupl KM. Postural imbalance: an early sign in HIV-1 infected patients. Eur Arch Psychiatry Clin Neurosci 1992; 41:267-272.
15. Beckley DJ, Bastiaan BR, Martin EM, Panzer VP, Remler MP. Postural reflexes in patients with HIV-1 infection. Electroencephalogr Clin Neurophysiol 1998; 109:402-408.
16. Arendt G, Giesen VH, Hefter H, Theisen A. Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection. AIDS 2001; 15:493-500.
17. Arendt G, Hefter H, Buescher L, Hiperath F, Elsing C, Freund HJ. Improvement of motor performance of HIV-positive patients under AZT therapy. Neurology 1992; 42:891-896.
18. Bauer LO. Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal. Psychiatry Res 1993; 47:69-77.
19. Bauer LO. Psychomotor and electroencephalographic sequelae of cocaine dependence. In: Neurotoxicity and Neuropathology Associated With Cocaine Abuse (NIDA Research Monograph #163). Majewska MD (editor). Washington, D.C.: National Institute on Drug Abuse; 1996. pp. 66-93.
20. Buchner DM, Cress ME, Esselman PC, Margherita AJ, de Lateur BJ, Campbell AJ, Wagner EH. Factors associated with changes in gait speed in older adults. J Gerontol A Biol Sci Med Sci 1996; 51:M297-M302.
21. Gerr F, Letz R. Covariates of human peripheral nerve function: III. Effects of reported drinking. Neurotoxicol Teratol 1994; 16:113-122.
22. Lemke MR, Wendorff T, Mieth B, Buhl K, Linnemann M. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J Psychiatr Res 2000; 34:277-283.
23. Sullivan EV, Desmond JE, Lim KO, Pfefferbaum A. Speed and efficiency but not accuracy or timing deficits of limb movements in alcoholic men and women. Alcohol Clin Exper Res 2002; 26:705-713.
24. Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 2000; 24:611-621.
25. th ed. Washington, D.C., American Psychiatric Press; 1994.
26. Robins LN, Cottler L, Bucholz K, Compton, W. The Diagnostic Interview Schedule, Version IV. St. Louis: Washington University; 1995.
27. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients the addiction severity index. J Nerv Ment Dis 1980; 168:26-33.
28. Selzer ML. The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am J Psychiatry 1971; 127:1653-1658.
29. Skinner H. The Drug Abuse Screening Test. Addict Behav 1982; 7:363-371.
30. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Version II Manual. San Antonio, TX: Psychological Corporation/Harcourt Brace; 1996.
31. Kaufman AS, Kaufman NL. Kaufman Brief Intelligence Test. Circle Pines, MN: American Guidance Services; 1990.
32. O'Connell JM, Braitstein P, Hogg RS, Yip B, Craib KJ, O'Shaughnessy MV, Montaner JS, Burdge DR. Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population based antiretroviral drug treatment programme. Antivir Ther 2003; 8:569-576.
33. Starace F, Ammassari A, Trotta MP, Murri R, DeLongis P, Izzo C, Scalzini A, d'Arminio Monforte A, Wu AW, Antinori A, AdlCoNA Study Group, NeurolCoNA Study Group. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31 (Suppl):S136-S139.
34. Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003; 169:656-661.
35. Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P, Ryan E, Yakoushina T, Khan S, Mahboob R, Naseer M, Dorfman D, Sharp V, Manhattan HIV Brain Bank. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 2004; 61:546-551.
36. Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K, Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Incidence of and risk factors for HIV associated distal sensory polyneuropathy. Neurology 2002; 58:1764-1768.
37. Bozzette SA, Santangelo J, Villasana D, Fraser A, Wright B, Jacobsen C, Hayden E, Schnack J, Spector SA, Richman DD. Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicity. J Acquir Immune Defic Syndr 1991; 4:851-855.
38. Skowron G, Bozzettee SA, Lim L, Pettinelli CB, Schaumburg HH, Arezzo J, Fischl MA, Powderly WG, Gocke DJ, Richman DD. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med 1993; 118:321-330.
39. Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 2001; 6:14-20.
40. Scarsella A, Coodley G, Shalit P, Anderson R, Fisher RL, Liao Q, Ross LL, Hernandez JE. Stavudine associated peripheral neuropathy in zidovudine-naïve patients: effects of stavudine exposure and antiretroviral experience. Adv Ther 2002; 19:1-8.
41. King MB, Judge JO, Wolfson LI. Functional base of support decreases with age. J Gerontol 1994; 49:M258-M263.
42. NeuroCom International, Inc. Equitest System Operator's Manual. Clackamas, OR: NeuroCom International Inc., 1989.
43. Arezzo JC. Quantitative sensory testing of vibration threshold: Vibratron II. Rationale and methods. Clifton, NJ: Physitemp Intruments, Inc. (unpublished report), 1993.